Saag MS - Search Results

1

Prolonged suppression of human immunodeficiency virus type 1 RNA during dual nucleoside reverse-transcriptase-inhibitor therapy in clinical practice.

Hoesley CJ, Saag MS, Chatham A, Kilby JM. Hoesley CJ, et al. Among authors: saag ms. Clin Infect Dis. 2000 Oct;31(4):1095-7. doi: 10.1086/318143. Clin Infect Dis. 2000. PMID: 11049795

2

Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: adverse effects.

Saag MS. Saag MS. Hosp Pract (Off Ed). 1992 Aug;27 Suppl 2:26-36. doi: 10.1080/21548331.1992.11705597. Hosp Pract (Off Ed). 1992. PMID: 1324255 Review.

3

High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.

Saag MS, Crain MJ, Decker WD, Campbell-Hill S, Robinson S, Brown WE, Leuther M, Whitley RJ, Hahn BH, Shaw GM. Saag MS, et al. J Infect Dis. 1991 Jul;164(1):72-80. doi: 10.1093/infdis/164.1.72. J Infect Dis. 1991. PMID: 1676046

4

Is there a role for non-nucleoside reverse transcriptase inhibitors in the treatment of HIV infection?

Kilby JM, Saag MS. Kilby JM, et al. Among authors: saag ms. Infect Agents Dis. 1994 Dec;3(6):313-23. Infect Agents Dis. 1994. PMID: 7534192 Review.

5

Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.

Kappes JC, Saag MS, Shaw GM, Hahn BH, Chopra P, Chen S, Emini EA, McFarland R, Yang LC, Piatak M Jr, et al. Kappes JC, et al. Among authors: saag ms. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):139-49. doi: 10.1097/00042560-199510020-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7552477 Clinical Trial.

6

A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group.

Saag MS, Emini EA, Laskin OL, Douglas J, Lapidus WI, Schleif WA, Whitley RJ, Hildebrand C, Byrnes VW, Kappes JC, et al. Saag MS, et al. N Engl J Med. 1993 Oct 7;329(15):1065-72. doi: 10.1056/NEJM199310073291502. N Engl J Med. 1993. PMID: 7690462 Free article. Clinical Trial.

7

Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.

Powderly WG, Cloud GA, Dismukes WE, Saag MS. Powderly WG, et al. Among authors: saag ms. Clin Infect Dis. 1994 May;18(5):789-92. doi: 10.1093/clinids/18.5.789. Clin Infect Dis. 1994. PMID: 8075272 Clinical Trial.

8

HIV viral load markers in clinical practice.

Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, Volberding PA. Saag MS, et al. Nat Med. 1996 Jun;2(6):625-9. doi: 10.1038/nm0696-625. Nat Med. 1996. PMID: 8640545 Review.

9

Effect of antiretroviral therapy on plasma HIV RNA.

Saag MS. Saag MS. J Biol Regul Homeost Agents. 1995 Jul-Sep;9(3):105-6. J Biol Regul Homeost Agents. 1995. PMID: 8782017 Review. No abstract available.

10

Clinical experience with non-nucleoside reverse transcriptase inhibitors: L-697,661 and nevirapine.

Kilby JM, Saag MS. Kilby JM, et al. Among authors: saag ms. Adv Exp Med Biol. 1996;394:291-8. doi: 10.1007/978-1-4757-9209-6_26. Adv Exp Med Biol. 1996. PMID: 8815693 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

516 results

Search Page

Filters